Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Respiratory medicine, Birmingham Women's and Children's Hospitals NHS Foundation Trust, Birmingham, UK
BMJ Open. 2022 Aug 19;12(8):e058356. doi: 10.1136/bmjopen-2021-058356.
Asthma is the most common chronic respiratory disease in children and adults. Asthma results in significant disease-related morbidity, healthcare costs and, in some cases, death. Despite efforts through implementation of national guidelines to improve asthma care, the UK has one of the highest asthma-related morbidity and mortality rates in the western world. New approaches are necessary to prevent asthma attacks in children and adults. The objectives of this study are to assess the association between demographic and clinical factors and asthma-related hospital admissions in children and adults, describe the epidemiology of asthma phenotypes among hospital attenders, and externally validate existing asthma risk prediction models.
This is a retrospective cohort study of children and adults with asthma. Data will be extracted from the Clinical Practice Research Datalink (CPRD) Aurum database, which holds anonymised primary care data for over 13 million actively registered patients and covers approximately 19% of the UK population. The primary outcome will be asthma-related hospital admissions. The secondary outcomes will be prescriptions of short courses of oral corticosteroids (as a surrogate measure for asthma exacerbations), a composite outcome measure including hospital admissions and prescriptions of short courses of oral corticosteroids and delivery of asthma care management following hospital discharge. The primary analysis will use a Poisson regression model to assess the association between demographic and clinical risk factors and the primary and secondary outcomes. Latent class analysis will be used to identify distinct subgroups, which will further our knowledge on potential phenotypes of asthma among patients at high risk of asthma-related hospital admissions. A Concordance statistic (C-statistic) and logistic regression model will also be used to externally validate existing risk prediction models for asthma-related hospitalisations to allow for the optimal model to be identified and evaluated provide evidence for potential use of the optimal performing risk prediction model in primary care.
This study was approved by the CPRD Independent Scientific Advisory Committee (reference number: 21_000512). Findings from this study will be published in a peer-reviewed journal and disseminated at national and international conferences.
哮喘是儿童和成人中最常见的慢性呼吸道疾病。哮喘会导致显著的与疾病相关的发病率、医疗保健费用,在某些情况下还会导致死亡。尽管通过实施国家指南来改善哮喘护理做出了努力,但英国仍是西方世界中与哮喘相关发病率和死亡率最高的国家之一。需要采取新的方法来预防儿童和成人的哮喘发作。本研究的目的是评估人口统计学和临床因素与儿童和成人哮喘相关住院之间的关联,描述医院就诊者中哮喘表型的流行病学,并对外科现有哮喘风险预测模型进行验证。
这是一项针对哮喘儿童和成人的回顾性队列研究。数据将从临床实践研究数据链接(CPRD)Aurum 数据库中提取,该数据库包含超过 1300 万主动注册患者的匿名初级保健数据,涵盖了英国约 19%的人口。主要结局将是哮喘相关的住院治疗。次要结局将是短期口服皮质类固醇处方(作为哮喘加重的替代测量)、包括住院和短期口服皮质类固醇处方以及出院后提供哮喘护理管理的复合结局测量。主要分析将使用泊松回归模型来评估人口统计学和临床危险因素与主要和次要结局之间的关系。潜在类别分析将用于识别不同的亚组,这将进一步了解高哮喘相关住院风险患者中哮喘的潜在表型。还将使用一致性统计量(C 统计量)和逻辑回归模型对外科现有哮喘相关住院风险预测模型进行验证,以确定和评估最佳模型,为初级保健中潜在使用最佳风险预测模型提供证据。
这项研究已获得 CPRD 独立科学咨询委员会的批准(参考编号:21_000512)。本研究的结果将发表在同行评议的期刊上,并在国内和国际会议上进行传播。